SER logo

Serina Therapeutics (SER) Financials

Balance sheets

30 Sept 202430 June 202431 Mar 202430 Sept 202301 June 202331 Mar 202301 Dec 2022

Total Assets

$7.4 M(-30.6%)$10.7 M(-1.4%)$10.9 M-$9.7 M-$858.0 K

Current Assets

$5.4 M(-39.2%)$8.9 M(-0.2%)$8.9 M-$8.7 M-$548.6 K

Non Current Assets

$2.0 M(+12.3%)$1.8 M(-6.7%)$1.9 M-$1.0 M-$309.5 K

Total Liabilities

$21.3 M(-21.5%)$27.1 M(+78.7%)$15.2 M-$45.0 M-$38.6 M

Current Liabilities

$13.5 M(+7.0%)$12.6 M(-10.1%)$14.1 M-$8.6 M-$437.7 K

Long Term Liabilities

$7.7 M(-46.4%)$14.5 M(+1208.1%)$1.1 M-$36.4 M-$38.2 M

Shareholders Equity

-$13.8 M(+15.8%)-$16.4 M(-279.7%)-$4.3 M--$35.3 M--$37.8 M

Book Value

-$14.3 M(+15.5%)-$16.9 M(-246.2%)-$4.9 M--$35.3 M--$37.8 M

Working Capital

-$8.1 M(-117.7%)-$3.7 M(+27.4%)-$5.1 M-$155.4 K-$110.9 K

Cash And Cash Equivalents

$3.2 M(-47.5%)$6.1 M(-30.4%)$8.7 M-$8.7 M-$532.2 K

Accounts Payable

$1.7 M(+40.9%)$1.2 M(-53.8%)$2.6 M-$360.3 K-$143.3 K

Accounts Receivable

--$65.0 K---$0.0

Short Term Debt

$10.5 M(+0.2%)$10.4 M(+7.2%)$9.7 M-$7.8 M-$128.4 K

Long Term Debt

$1.0 M(-4.7%)$1.1 M(-4.6%)$1.1 M-$388.3 K-$1.7 M

Total Debt

$11.5 M(-2.1%)$11.7 M(+5.7%)$11.1 M-$8.2 M-$1.8 M

Debt To Equity

-0.8(-15.3%)-0.7(+72.0%)-2.6--0.2--0.1

Current Ratio

0.4(-43.7%)0.7(+10.9%)0.6-1.0-1.3

Quick Ratio

-------

Inventory

-------

Retained Earnings

-$21.8 M(+6.1%)-$23.2 M(-326.6%)-$5.4 M--$36.0 M--$38.4 M

PB Ratio

-4.7(+13.9%)-5.5(+80.3%)-27.7----

Income statements

30 Sept 202430 June 202431 Mar 202430 Sept 202301 June 202331 Mar 202301 Dec 2022

EPS

$0.1(-74.5%)$0.5(+115.1%)-$3.4(-1569.6%)$0.2-$0.2-

TTM EPS

-$2.7(-3.8%)-$2.6(+16.2%)-$3.1(-832.6%)$0.4-$0.2-

Revenue

$0.0(0%)$0.0(0%)$0.0(0%)$0.0-$0.0-

TTM Revenue

$0.0(0%)$0.0(0%)$0.0(0%)$0.0-$0.0-

Total Expenses

$5.3 M(+37.4%)$3.9 M(+66.6%)$2.3 M(+58.6%)$1.5 M-$962.0 K-

Operating Expenses

$5.3 M(+37.4%)$3.9 M(+66.6%)$2.3 M(+58.6%)$1.5 M-$962.0 K-

Cost Of Goods Sold

-------

TTM Cost Of Goods Sold

-------

Gross Profit

-------

TTM Gross Profit

-------

Gross Margin

-------

Operating Profit

-$5.3 M(-37.4%)-$3.9 M(-66.6%)-$2.3 M(-58.6%)-$1.5 M--$962.0 K-

TTM Operating Profit

-$11.5 M(-50.3%)-$7.7 M(-102.2%)-$3.8 M(-56.0%)-$2.4 M--$962.0 K-

Operating Margin

-------

Net Income

$1.4 M(-72.9%)$5.2 M(+155.1%)-$9.4 M(-638.6%)$1.8 M-$1.7 M-

TTM Net Income

-$2.8 M(-13.8%)-$2.5 M(+67.7%)-$7.7 M(-325.4%)$3.4 M-$1.7 M-

Net Margin

-------

EBIT

$1.4 M(-74.2%)$5.4 M(+158.0%)-$9.3 M(-604.2%)$1.9 M-$1.7 M-

TTM EBIT

-$2.5 M(-21.9%)-$2.1 M(+72.4%)-$7.5 M(-308.2%)$3.6 M-$1.7 M-

EBITDA

-$5.2 M(-36.6%)-$3.8 M(-66.3%)-$2.3 M(-76.1%)-$1.3 M--$949.0 K-

TTM EBITDA

-$11.3 M(-52.7%)-$7.4 M(-106.1%)-$3.6 M(-59.8%)-$2.3 M--$949.0 K-

Selling, General & Administrative Expenses

$2.9 M(+25.3%)$2.3 M(+90.4%)$1.2 M(+37.2%)$889.0 K-$593.0 K-

TTM SG&A

$6.5 M(+45.6%)$4.4 M(+110.2%)$2.1 M(+42.3%)$1.5 M-$593.0 K-

Depreciation And Amortization

$56.0 K(-1.8%)$57.0 K(+128.0%)$25.0 K(-53.7%)$54.0 K-$13.0 K-

TTM D&A

$138.0 K(+1.5%)$136.0 K(+72.2%)$79.0 K(+17.9%)$67.0 K-$13.0 K-

Interest Expense

$16.0 K(-93.4%)$242.0 K(+144.4%)$99.0 K(-1.0%)$100.0 K-$86.0 K-

TTM Interest Expense

$357.0 K(-19.1%)$441.0 K(+121.6%)$199.0 K(+7.0%)$186.0 K-$86.0 K-

Income Tax

-------

TTM Income Tax

-------

PE Ratio

---56.5-118.4-

PS Ratio

-------

Cashflow statements

30 Sept 202430 June 202431 Mar 202430 Sept 202301 June 202331 Mar 202301 Dec 2022

Cash From Operations

-$3.0 M(+63.0%)-$8.0 M(-407.9%)-$1.6 M(-54.0%)-$1.0 M--$709.0 K-

TTM CFO

-$12.5 M(-18.3%)-$10.6 M(-307.9%)-$2.6 M(-50.1%)-$1.7 M--$709.0 K-

Cash From Investing

-$3000.0(-100.0%)$0.0(+100.0%)-$14.0 K(+88.2%)-$119.0 K-$0.0-

TTM CFI

-$17.0 K(+87.2%)-$133.0 K(0%)-$133.0 K(-11.8%)-$119.0 K-$0.0-

Cash From Financing

$86.0 K(-98.4%)$5.4 M(+96.7%)$2.7 M(+136300.0%)$2000.0-$10.1 M-

TTM CFF

$8.2 M(+1.0%)$8.1 M(+196.6%)$2.7 M(-73.0%)$10.1 M-$10.1 M-

Free Cash Flow

-$3.0 M(+63.0%)-$8.0 M(-403.4%)-$1.6 M(-39.2%)-$1.1 M--$709.0 K-

TTM FCF

-$12.6 M(-17.0%)-$10.7 M(-292.9%)-$2.7 M(-47.6%)-$1.9 M--$709.0 K-

CAPEX

$3000.0-$14.0 K(-88.2%)$119.0 K---

TTM CAPEX

$17.0 K-$133.0 K(+11.8%)$119.0 K---

Dividends Paid

-------

TTM Dividends Paid

-------

TTM Dividend Per Share

-------

TTM Dividend Yield

-------

Payout Ratio

-------